1.	AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors Phase: Phase IV Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 2006-00055-18, NCT00415103
2.	Granisetron, Dexamethasone, Prochlorperazine, Aprepitant, and Palonosetron in Preventing Nausea in Patients Undergoing Chemotherapy for Breast Cancer Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000544841, U10CA037420, URCC-04-02, URCC-U1105, U1105, NCT00475085
3.	Phase III Randomized Study of Acupressure to Control Chemotherapy-Induced Nausea in Children With Central Nervous System or Solid Tumors Receiving Cisplatin-Containing Chemotherapy Phase: Phase III Type: Supportive care Status: Closed Age: 4 to 18 Sponsor: NCI Protocol IDs: SCUSF-1202, COG-ACCL1032, ACCL1032, NCT01346267
4.	Phase II Study of CDDP/CBDCA with Ondansetron or Granisetron and G-CSF in Patients with Stage III/IV Epithelial Ovarian Cancer Phase: Phase II Type: Supportive care, Treatment Status: Closed Age: no age specified Sponsor: Other Protocol IDs: NBSG-9204, NCI-V92-0153
5.	Aprepitant, Granisetron, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Cyclophosphamide Before a Stem Cell Transplant Phase: No phase specified Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000456201, P30CA022453, WSU-D-2797, WSU-0504001728, NCT00293384